Want to see AU:SHG full AI Analyst Report?
SHG Stock Chart & Stats
AU$0.26
AU$0.03(15.38%)
At close: 4:00 PM EST
AU$0.26
AU$0.03(15.38%)
Day’s Range― - ―
52-Week RangeAU$0.17 - AU$0.41
Previous CloseN/A
Volume808.83K
Average Volume (3M)1.03M
Market Cap
AU$71.23M
Enterprise ValueAU$60.72M
Total Cash (Recent Filing)AU$11.06M
Total Debt (Recent Filing)AU$113.71K
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding323,773,100
10 Day Avg. Volume889,327
30 Day Avg. Volume1,029,223
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)6.82
Price to Sales (P/S)160.16
P/FCF Ratio-37.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Reported LeverageZero reported debt in 2025 and a large equity base materially reduce near-term solvency risk and lower fixed financing costs. This structural balance sheet strength improves financial flexibility, giving management time and options to execute strategy or raise capital without immediate refinancing pressure.
Predictable Cash Burn RelationshipFree cash flow roughly tracking net losses implies operating cash outflows align with accounting losses, making the burn rate more transparent and predictable. This consistency aids multi-month forecasting and financing planning, improving the firm's ability to manage runway and negotiate capital on clearer terms.
Demonstrated Prior Revenue GrowthRevenue growth in 2024 before a sharp 2025 decline demonstrates the business can scale under favorable conditions and suggests underlying product-market fit. Such prior growth indicates recoverable demand that management could re-leverage if operational issues are addressed and sales momentum is restored.
Bears Say
Persistent UnprofitabilityConsistent, extreme losses and very negative margins indicate the core business is structurally unprofitable and faces fundamental margin problems. Over months this will require material margin improvement, aggressive cost reductions, or continued external funding to prevent progressive erosion of cash and shareholder value.
Weak Cash GenerationPersistent negative operating cash flow and negative free cash flow across years show the company cannot self-fund operations, driving continuous cash burn. Over a 2-6 month horizon this sharply increases dependence on external financing, raising dilution risk and limiting ability to invest in growth initiatives.
Capital Structure Volatility / Dilution RiskHistorical capital structure volatility — negative equity in 2020 and very high leverage (debt-to-equity ~40x in 2023) — signals repeated financing stress and likely future recapitalizations. This raises structural dilution and execution risk, complicating long-term planning and investor confidence.
Singular Health Group Ltd News
SHG FAQ
What was Singular Health Group Ltd’s price range in the past 12 months?
Singular Health Group Ltd lowest share price was AU$0.17 and its highest was AU$0.41 in the past 12 months.
What is Singular Health Group Ltd’s market cap?
Singular Health Group Ltd’s market cap is AU$71.23M.
When is Singular Health Group Ltd’s upcoming earnings report date?
Singular Health Group Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 56 days.
How were Singular Health Group Ltd’s earnings last quarter?
Singular Health Group Ltd released its earnings results on Feb 23, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.01.
Is Singular Health Group Ltd overvalued?
According to Wall Street analysts Singular Health Group Ltd’s price is currently Overvalued.
Does Singular Health Group Ltd pay dividends?
Singular Health Group Ltd does not currently pay dividends.
What is Singular Health Group Ltd’s EPS estimate?
Singular Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Singular Health Group Ltd have?
Singular Health Group Ltd has 323,773,100 shares outstanding.
What happened to Singular Health Group Ltd’s price movement after its last earnings report?
Singular Health Group Ltd reported an EPS of -AU$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.704%.
Which hedge fund is a major shareholder of Singular Health Group Ltd?
Currently, no hedge funds are holding shares in AU:SHG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Singular Health Group Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:SHG Sentiment 97%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
252.94%
12-Months-Change
Fundamentals
Return on Equity
-59.96%
Trailing 12-Months
Asset Growth
145.48%
Trailing 12-Months
Company Description
Singular Health Group Ltd
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of anatomy, drawing upon standard radiological imaging. Among its key offerings are the 3Dicom Viewer, a cross-compatible software application designed for users to engage with conventional 2D medical images; 3DicomVSP, a complete system for surgical planning; Health Academy, a adaptable, multi-language platform delivering structured, curriculum-aligned educational modules; and GeoVR, a cloud-based solution specifically engineered for the mineral resources industry. The company, founded in 2017, is headquartered in Subiaco, Australia.
Technical Analysis
Mach7 Technologies
―
Beamtree Holdings Ltd
―
―
Alcidion Group Limited
―
PainChek Ltd
―
Options Prices
Currently, No data available
---